| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.73▼ | 1.72▼ | 1.72▼ | 1.74▼ | 1.88▼ |
| MA10 | 1.73▼ | 1.74▼ | 1.71▲ | 1.80▼ | 2.01▼ |
| MA20 | 1.73▼ | 1.70▲ | 1.71▲ | 1.88▼ | 2.11▼ |
| MA50 | 1.70▲ | 1.75▼ | 1.79▼ | 2.04▼ | 2.12▼ |
| MA100 | 1.75▼ | 1.81▼ | 1.85▼ | 2.13▼ | 8.88▼ |
| MA200 | 1.81▼ | 1.90▼ | 1.95▼ | 1.98▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.005▲ | 0.009▲ | -0.010▼ | N/A |
| RSI | 49.966▼ | 48.539▼ | 46.862▼ | 40.794▼ | 39.751▼ |
| STOCH | 32.381 | 29.251 | 69.082 | 27.257 | 18.508▼ |
| WILL %R | -80.000▼ | -52.174 | -34.286 | -66.667 | -85.577▼ |
| CCI | -73.939 | -24.454 | 37.881 | -108.271▼ | -171.600▼ |
|
Thursday, December 06, 2018 08:10 AM
Axovant Sciences (AXON-0.9%) announces that the FDA is on board with the inclusion of data on its first-generation version of gene therapy AXO-Lenti-PD, called ProSavin, to support the development ...
|
|
Thursday, December 06, 2018 03:23 AM
The IPO — which is expected to launch this week — will be the largest-ever biotech market debut, eclipsing previous record-holders like Axovant Sciences (Nasdaq: AXON) and Allogene Therapeutics (Nasda...
|
|
Thursday, December 06, 2018 03:15 AM
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Axovant Sciences (NASDAQ: AXON) today announced feedback from a face-to-face pre-IND mee...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/12/18 | 1.77 | 1.78 | 1.68 | 1.71 | 264,894 |
| 06/12/18 | 1.65 | 1.78 | 1.56 | 1.77 | 621,025 |
| 04/12/18 | 1.76 | 1.77 | 1.64 | 1.65 | 729,835 |
| 03/12/18 | 1.83 | 1.85 | 1.76 | 1.78 | 409,254 |
| 30/11/18 | 1.83 | 1.83 | 1.77 | 1.81 | 227,488 |
| 29/11/18 | 1.85 | 1.88 | 1.77 | 1.82 | 270,231 |
| 28/11/18 | 1.82 | 1.87 | 1.79 | 1.86 | 272,454 |
| 27/11/18 | 1.91 | 1.91 | 1.80 | 1.81 | 377,294 |
| 26/11/18 | 1.84 | 1.95 | 1.84 | 1.92 | 583,933 |
| 23/11/18 | 1.93 | 1.95 | 1.81 | 1.82 | 180,158 |
|
|
||||
|
|
||||
|
|
||||
|
|